Localization of endothelin-1 (ET-1), ET-2, and ET-3, mouse VIC, and sarafotoxin S6b binding sites in mammalian heart and kidney
- PMID: 1725315
- DOI: 10.1097/00005344-199100177-00042
Localization of endothelin-1 (ET-1), ET-2, and ET-3, mouse VIC, and sarafotoxin S6b binding sites in mammalian heart and kidney
Abstract
Quantitative in vitro receptor autoradiography was used to identify and compare binding sites for endothelin-1 (ET-1), ET-2, and ET-3, mouse vasoactive intestinal contractor (VIC), and sarafotoxin S6b in human, porcine, and rat cardiac and renal tissues. In the rat kidney, the highest densities of binding sites for all five labeled peptides were present in the glomeruli, with lower levels in the papilla, cortex, and inner band of the medulla. A similar pattern was found in porcine and human kidney except that no discrete glomerular binding could be detected. In the heart, higher densities were detected in the atria compared to the ventricle. Although the pattern of binding in cardiac and renal tissue was similar for all four labeled ET isoforms, nonspecific binding was consistently higher with ET-3, resulting in lower levels of specific binding. These results suggest that these peptides could be acting via the same population of binding sites, but multiple receptor subtypes may exist that differ in their rank order of affinity for the ET isoforms and sarafotoxin S6b, as proposed in other tissues.
Similar articles
-
In vitro autoradiographic endothelin-1 binding sites and sarafotoxin S6B binding sites in rat tissues.Clin Exp Pharmacol Physiol. 1991 Jul;18(7):509-15. doi: 10.1111/j.1440-1681.1991.tb01485.x. Clin Exp Pharmacol Physiol. 1991. PMID: 1655320
-
[Comparison between endothelin binding sites and sarafotoxin S6B binding sites in rat tissues: studies by quantitative in vitro receptor autoradiography].Nihon Naibunpi Gakkai Zasshi. 1991 Aug 20;67(8):849-60. doi: 10.1507/endocrine1927.67.8_849. Nihon Naibunpi Gakkai Zasshi. 1991. PMID: 1667523 Japanese.
-
Similar distribution of [125I]sarafotoxin-6b and [125I]endothelin-1, -2, -3 binding sites in the human kidney.Eur J Pharmacol. 1990 Feb 6;176(2):233-6. doi: 10.1016/0014-2999(90)90534-d. Eur J Pharmacol. 1990. PMID: 2155801
-
Endothelins and sarafotoxins: physiological regulation, receptor subtypes and transmembrane signaling.Trends Biochem Sci. 1991 Jul;16(7):261-4. doi: 10.1016/0968-0004(91)90100-a. Trends Biochem Sci. 1991. PMID: 1656557 Review.
-
Similarities in mode and sites of action of sarafotoxins and endothelins.Trends Pharmacol Sci. 1989 Jun;10(6):212-4. doi: 10.1016/0165-6147(89)90261-7. Trends Pharmacol Sci. 1989. PMID: 2549664 Review. No abstract available.
Cited by
-
Failure of BQ123, a more potent antagonist of sarafotoxin 6b than of endothelin-1, to distinguish between these agonists in binding experiments.Br J Pharmacol. 1996 May;118(2):335-42. doi: 10.1111/j.1476-5381.1996.tb15407.x. Br J Pharmacol. 1996. PMID: 8735635 Free PMC article.
-
Endothelin ETA and ETB mRNA and receptors expressed by smooth muscle in the human vasculature: majority of the ETA sub-type.Br J Pharmacol. 1995 Mar;114(6):1110-6. doi: 10.1111/j.1476-5381.1995.tb13322.x. Br J Pharmacol. 1995. PMID: 7620699 Free PMC article.
-
Positron emission tomography using 18F-labelled endothelin-1 reveals prevention of binding to cardiac receptors owing to tissue-specific clearance by ET B receptors in vivo.Br J Pharmacol. 2005 Jan;144(1):115-22. doi: 10.1038/sj.bjp.0706064. Br J Pharmacol. 2005. PMID: 15644875 Free PMC article.
-
Endothelin.Pharmacol Rev. 2016 Apr;68(2):357-418. doi: 10.1124/pr.115.011833. Pharmacol Rev. 2016. PMID: 26956245 Free PMC article. Review.
-
[125I]-PD151242: a selective ligand for endothelin ETA receptors in human kidney which localizes to renal vasculature.Br J Pharmacol. 1994 Dec;113(4):1303-10. doi: 10.1111/j.1476-5381.1994.tb17140.x. Br J Pharmacol. 1994. PMID: 7534185 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources